Literature DB >> 17683970

RIG-I family RNA helicases: cytoplasmic sensor for antiviral innate immunity.

Mitsutoshi Yoneyama1, Takashi Fujita.   

Abstract

Viral infection is detected by cellular sensors as foreign nucleic acid and initiates innate antiviral responses, including the activation of type I interferon (IFN) and proinflammatory cytokines. Recent advances in cytoplasmic virus sensors highlight their essential role in the induction of innate immunity. Moreover, it is intriguing to understand how they can discriminate innate RNA from viral foreign RNA. In this mini-review, we focus on these cytoplasmic virus sensors, termed retinoic acid inducible gene-I (RIG-I)-like receptors (RLRs), and discuss their function in the innate immune system.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17683970     DOI: 10.1016/j.cytogfr.2007.06.023

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  68 in total

1.  Leucine-rich repeat (in Flightless I) interacting protein-1 regulates a rapid type I interferon response.

Authors:  Asen Bagashev; Michael C Fitzgerald; David F Larosa; Patrick P Rose; Sara Cherry; Alfred C Johnson; Kathleen E Sullivan
Journal:  J Interferon Cytokine Res       Date:  2010-06-29       Impact factor: 2.607

2.  Double Plant Homeodomain Fingers 2 (DPF2) Promotes the Immune Escape of Influenza Virus by Suppressing Beta Interferon Production.

Authors:  Dongjo Shin; Jihye Lee; Ji Hoon Park; Ji-Young Min
Journal:  J Virol       Date:  2017-05-26       Impact factor: 5.103

3.  NALP1 influences susceptibility to human congenital toxoplasmosis, proinflammatory cytokine response, and fate of Toxoplasma gondii-infected monocytic cells.

Authors:  William H Witola; Ernest Mui; Aubrey Hargrave; Susan Liu; Magali Hypolite; Alexandre Montpetit; Pierre Cavailles; Cordelia Bisanz; Marie-France Cesbron-Delauw; Gilbert J Fournié; Rima McLeod
Journal:  Infect Immun       Date:  2010-11-22       Impact factor: 3.441

Review 4.  Toll-like receptors regulation of viral infection and disease.

Authors:  Joseph M Thompson; Akiko Iwasaki
Journal:  Adv Drug Deliv Rev       Date:  2007-12-28       Impact factor: 15.470

5.  A critical link between Toll-like receptor 3 and type II interferon signaling pathways in antiviral innate immunity.

Authors:  Hideo Negishi; Tomoko Osawa; Kentaro Ogami; Xinshou Ouyang; Shinya Sakaguchi; Ryuji Koshiba; Hideyuki Yanai; Yoshinori Seko; Hiroshi Shitara; Keith Bishop; Hiromichi Yonekawa; Tomohiko Tamura; Tsuneyasu Kaisho; Choji Taya; Tadatsugu Taniguchi; Kenya Honda
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-11       Impact factor: 11.205

6.  Nucleoside modifications modulate activation of the protein kinase PKR in an RNA structure-specific manner.

Authors:  Subba Rao Nallagatla; Philip C Bevilacqua
Journal:  RNA       Date:  2008-04-21       Impact factor: 4.942

7.  Dengue virus subverts the interferon induction pathway via NS2B/3 protease-IκB kinase epsilon interaction.

Authors:  Yesseinia I Angleró-Rodríguez; Petraleigh Pantoja; Carlos A Sariol
Journal:  Clin Vaccine Immunol       Date:  2013-10-30

8.  Characterization of retinoic acid-inducible gene-I expression in primary murine glia following exposure to vesicular stomatitis virus.

Authors:  Samantha R Furr; Vinita S Chauhan; David Sterka; Valery Grdzelishvili; Ian Marriott
Journal:  J Neurovirol       Date:  2008-11       Impact factor: 2.643

9.  RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III-transcribed RNA intermediate.

Authors:  Andrea Ablasser; Franz Bauernfeind; Gunther Hartmann; Eicke Latz; Katherine A Fitzgerald; Veit Hornung
Journal:  Nat Immunol       Date:  2009-07-16       Impact factor: 25.606

10.  Porcine Epidemic Diarrhea Virus 3C-Like Protease Regulates Its Interferon Antagonism by Cleaving NEMO.

Authors:  Dang Wang; Liurong Fang; Yanling Shi; Huan Zhang; Li Gao; Guiqing Peng; Huanchun Chen; Kui Li; Shaobo Xiao
Journal:  J Virol       Date:  2015-12-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.